Home - Onco'Zine

Moving Diagnostics Out of the Lab: Electrochemical Sensor for a Wide Range of Applications

Lindsay Brownell - November 11, 2019

Study Shows Oxygen-starved Cancer Cells have a Survival Advantage Promoting Cancer Spread

Michigan Oncology Quality Consortium Selects Varian to Support Transition to Value-Based Care

Trabectedin Shows Favorable Results in Routine Real-life Clinical Practice in Ovarian Cancer

Study Shows Exposure to Hematology in Medical School and Mentorship Vital to Future of the Field

FEATURED

Personalizing Cancer Treatment: Why Adaptive Therapy Isn’t There Yet

Yves Archambault - August 21, 2019

Common Myths about Colorectal Cancer Surgery Dispelled

Peter Hofland, Ph.D - July 22, 2019

Lung Cancer Among the Most Likely Conditions to Harm Patients who are Misdiagnosed

Peter Hofland, Ph.D - July 12, 2019

Debunking the 7 Most Common Misconceptions of Colorectal Cancer

Padma Sundar - March 19, 2019

Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices?

Eric T. Rosenthal - March 5, 2019

Diet and Cancer: What?s the Connection?

Mark Lowdell - February 20, 2019

CONFERENCE COVERAGE

Trabectedin Shows Favorable Results in Routine Real-life Clinical Practice in Ovarian Cancer

Peter Hofland, Ph.D - November 4, 2019

Tucatinib Shows Positive Results in Pivotal Trial in Locally Advanced HER2+ Breast Cancer

Peter Hofland, Ph.D - October 22, 2019

Zymeworks Awarded Best ADC Platform Technology at Annual Event

Peter Hofland, Ph.D - October 11, 2019

Celyad to Present Highlights of Allogeneic and Autologous NKG2D-based CAR-T therapies in mCRC

Peter Hofland, Ph.D - October 3, 2019

HER2-Targeted Bispecific Antibody ZW25 Shows Durable Response

Peter Hofland, Ph.D - October 2, 2019

ESMO 2019: New Approach in Treatment of Cholangiocarcinoma Shows Clinical Benefit

Peter Hofland, Ph.D - October 1, 2019

EDITORIAL

Broadening the Applicability of CAR-T Immunotherapy to Treat the Untreatable

Filippo Petti - October 24, 2019

Decreasing Breast Cancer False Positives with NV-VPAC1-PET Scan Technology

Jill Helmke - September 25, 2019

Transparency and Openness – A Must in the Murky World of Drug Pricing

LaMar Williams, Jr. - August 30, 2019

Medicare Coverage and Cancer – What you Need to Know

Danielle K. Roberts - August 12, 2019

No Rural Patient Left Behind: The Quest to Democratize Access to Cancer Care

Jani Ahonala - August 2, 2019

A Call to Action: Addressing Healthcare Diversity Among Hispanic/Latino People in the US

Mario Anglada - August 1, 2019

ERIC ROSENTHAL REPORTS

Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices?

Eric T. Rosenthal - March 5, 2019

Dr. Brawley Goes to Baltimore?and Washington

Eric T. Rosenthal - January 23, 2019

Jose Baselga Resigns as Co-Editor-in-Chief of Cancer Discovery

Eric T. Rosenthal - December 19, 2018

Professional Societies Disclose Their Disclosure Policies, But Why Won?t Some Discuss Them?

Eric T. Rosenthal - November 20, 2018

Otis Brawley Discusses Life After Leaving the American Cancer Society

Eric T. Rosenthal - November 16, 2018

How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?

Eric T. Rosenthal - October 9, 2018

EXPERT INTERVIEWS

Knowledge Alone is Not Enough to Defeat Cancer

Peter Hofland, Ph.D - November 2, 2018

Case Reports Show Potential of Cancer Immunotherapy for the Treatment of a Rare Form...

Sonia Portillo - July 11, 2017

An Intelligent Way to Deliver High Doses of a Very Potent Cytotoxic Agent

Shaun Mehr, Associate Publisher - November 21, 2016